Hisham Shiblaq served as Executive Vice President and Chief Commercial Officer at PROCEPT BioRobotics Corporation, a leader in robotic-assisted urological solutions. In this role, he oversaw the company's global commercial strategy, including sales, marketing, customer operations, and market access, driving the adoption of the AquaBeam Robotic System for benign prostatic hyperplasia (BPH) treatment. With more than 25 years of experience in the medical device industry, Shiblaq's expertise spans commercial leadership, business development, and revenue growth in high-growth medtech environments. Prior to PROCEPT, Shiblaq held senior executive positions at Boston Scientific, where he led North American commercial operations for endoscopy and urology divisions, achieving double-digit revenue growth and expanding market share through innovative go-to-market strategies. Earlier in his career, he progressed through sales and marketing roles at Intuitive Surgical and Johnson & Johnson, honing his skills in robotic surgery commercialization and physician education. His track record includes successfully launching multiple disruptive technologies, building high-performing teams, and navigating complex reimbursement landscapes. Under Shiblaq's leadership at PROCEPT, the company scaled its U.S. sales force from 50 to over 200 representatives, propelled annual revenue past $100 million, and supported a landmark IPO in 2022. Recognized with industry awards for commercial excellence, Shiblaq's strategic acumen positioned PROCEPT as a dominant player in urological robotics before his departure, leaving a lasting impact on the organization's growth trajectory.